Your browser doesn't support javascript.
loading
Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide.
Noonan, K L; North, S; Bitting, R L; Armstrong, A J; Ellard, S L; Chi, K N.
Afiliación
  • Noonan KL; Department of Medical Oncology, BC Cancer Agency, Vancouver Cancer Centre, Vancouver.
  • North S; Department of Medical Oncology, Cross Cancer Institute, Edmonton, Canada.
  • Bitting RL; Duke Cancer Institute and the Duke Prostate Center, Duke University, Durham, USA.
  • Armstrong AJ; Duke Cancer Institute and the Duke Prostate Center, Duke University, Durham, USA.
  • Ellard SL; Department of Medical Oncology, BC Cancer Agency, Cancer Centre for the Southern Interior, Kelowna, Canada.
  • Chi KN; Department of Medical Oncology, BC Cancer Agency, Vancouver Cancer Centre, Vancouver. Electronic address: kchi@bccancer.bc.ca.
Ann Oncol ; 24(7): 1802-1807, 2013 Jul.
Article en En | MEDLINE | ID: mdl-23585511

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Feniltiohidantoína / Neoplasias de la Próstata / Neoplasias Óseas / Androstenoles / Antineoplásicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2013 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Feniltiohidantoína / Neoplasias de la Próstata / Neoplasias Óseas / Androstenoles / Antineoplásicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2013 Tipo del documento: Article Pais de publicación: Reino Unido